Jay Lichter
Director at Janux Therapeutics, Inc. (JANX)
Jay Lichter has filed 21 insider reports with the SEC since February 2021, as director at Janux Therapeutics, Inc. (JANX) and director at Otonomy, Inc. (OTIC). Jay Lichter made no open-market purchases or sales in the last 12 months. The latest filing, on November 1, 2024, is a Form 144 notice: Jay Lichter plans to sell 1,139 JANX shares (~$60.7K).
- Filings
- 21
- Companies
- 2
- Bought on market
- $4.99M
- Sold on market
- $88.9M
Companies where Jay Lichter is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 7,000 | $4.99M | $82.3M | $5.87 | $10.08+72% | Nov 1, 2024 | |
| Director | $6.62M | Jun 23, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Nov 1, 2024~$60.7KJANXJay Lichter plans to sell 1,139 shares (~$60.7K)Form 144Planned sale
- Oct 28, 2024~$183KJANXJay Lichter plans to sell 3,419 shares (~$183K)Form 144Planned sale
- Oct 24, 2024~$263KJANXJay Lichter plans to sell 4,921 shares (~$263K)Form 144Planned sale
- Sep 13, 2024-$178KJANXLarge owner Lichter Jay exercised 3,815 shares at a strike of $17.29 and sold $178,084 worth of shares (3,815 units at $46.68)Form 4Exercise or conversion of a derivativeOpen-market sale
- Oct 21, 2024~$120KJANXJay Lichter plans to sell 2,434 shares (~$120K)Form 144Planned sale
- Oct 17, 2024~$92.2KJANXJay Lichter plans to sell 1,842 shares (~$92.2K)Form 144Planned sale
- Oct 16, 2024~$557KJANXJay Lichter plans to sell 10,957 shares (~$557K)Form 144Planned sale
- Sep 30, 2024~$44.3KJANXJay Lichter plans to sell 958 shares (~$44.3K)Form 144Planned sale
- Sep 27, 2024~$84.3KJANXJay Lichter plans to sell 1,826 shares (~$84.3K)Form 144Planned sale
- Sep 13, 2024~$178KJANXJay Lichter plans to sell 3,815 shares (~$178K)Form 144Planned sale
- Sep 9, 2024~$92.4KJANXJay Lichter plans to sell 2,182 shares (~$92.4K)Form 144Planned sale
- Jun 26, 2024JANXDirector Lichter Jay was granted 2,500 shares, increasing direct ownership by 55% to 7,083 unitsForm 4Grant or award
- Jun 3, 2024-$82.1MJANXLichter Jay sold $82,125,000 worth of shares (1,500,000 units at $54.75)Form 4Open-market sale
- Nov 13, 2023+$4.99MJANXLichter Jay bought $4,988,643 worth of shares (849,854 units at $5.87)Form 4Open-market purchase
- Jun 14, 2023JANXSEC Form 4 filed by Lichter JayForm 4Grant or award
- Jun 21, 2022OTICSEC Form 4 filed by Lichter JayForm 4Grant or award
- Jun 14, 2022JANXSEC Form 4 filed by Lichter JayForm 4Grant or award
- Jun 22, 2021OTICSEC Form 4 filed by Lichter JayForm 4Grant or award
- Mar 3, 2021-$867KOTICSEC Form 4: Jay Lichter sold $866,544 worth of Common Stock (321,180 units at $2.70)Form 4Open-market sale
- Mar 2, 2021-$2.56MOTICSEC Form 4: Jay Lichter sold $2,560,930 worth of Common Stock (893,828 units at $2.87)Form 4Open-market sale
- Feb 25, 2021-$3.19MOTICSEC Form 4: Jay Lichter sold $3,193,663 worth of Common Stock (1,082,353 units at $2.95)Form 4Open-market sale
Compare Jay Lichter with
- Jay Lichter vs Vickie L Capps2 shared
- Jay Lichter vs David Alan Campbell1 shared
- Jay Lichter vs Jake Simson1 shared
- Jay Lichter vs Natasha Hernday1 shared
- Jay Lichter vs Winston Kung1 shared
- Jay Lichter vs Eric Dobmeier1 shared
Other insiders at the same companies
- David Alan CampbellJANX
- Ra Capital Management, L.P.JANX
- Jake SimsonJANX
- Natasha HerndayJANX
- Winston KungJANX
- Eric DobmeierJANX
- Ronald W BarrettJANX
- Vickie L CappsJANX
- Janeen Noel DoyleJANX
- Maria DobekJANX
- William GoJANX
- Thomas DiRaimondoJANX
- Charles M. WinterJANX
- Zachariah McIverJANX
- Andrew Hollman MeyerJANX
- Byron RobinsonJANX
Questions about Jay Lichter
- What is Jay Lichter's role at Janux Therapeutics, Inc.?
- Jay Lichter reports to the SEC as director at Janux Therapeutics, Inc. (JANX), according to the latest filing on November 1, 2024. Jay Lichter has also filed as director at Otonomy, Inc. (OTIC).
- How many shares does Jay Lichter own?
- After the latest filing that states it, Jay Lichter directly owned 7,000 shares of Janux Therapeutics, Inc. (JANX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Jay Lichter bought or sold stock recently?
- The most recent open-market purchase was on November 13, 2023: bought 849,854 shares of Janux Therapeutics, Inc. (JANX) for $4.99M at an average of $5.87. The most recent open-market sale was on September 13, 2024: sold 3,815 shares of Janux Therapeutics, Inc. (JANX) for $178K at an average of $46.68.
- How do I get alerts when Jay Lichter files?
- Follow Jay Lichter on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Jay Lichter (SEC CIK 0001376355). Totals count each trade once, skipping amendments whose original is on file, from Feb 26, 2021 on. View on SEC EDGAR · Get this as JSON